Collaboration will pursue therapeutic targets focused on immunology and other indications Avidity to receive an upfront payment of $20 million and an investment of $15 million Avidity eligible to receive up to approximately $405 million per target in development and commercialization milestones, plus royalties INDIANAPOLIS, IN, and LA JOLLA, CA — April 22, 2019 /PRNewswire/ … Continue reading Lilly and Avidity Biosciences Announce Licensing and Research Collaboration